DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

10355	Companies
215502	Keywords
145322	Articles
114166	Press releases

Home
Companies
DBV TECHNOLOGIES

BRIEF

published on 03/02/2026 at 15:53, 2 months 4 days ago

Franchissement de seuils par J.P. Morgan dans DBV Technologies

Franchissement De Seuils Equity Swaps DBV Technologies J.P. Morgan Actions Et Droits De Vote
PRESS RELEASE

published on 03/02/2026 at 15:48, 2 months 4 days ago

Franchissement de seuils
J.P. Morgan Chase & Co. déclare détenir 7,91% du capital de DBV Technologies après avoir franchi les seuils de 10% en baisse le 24/02/2026

Capital AMF Franchissement De Seuils DBV Technologies J.P. Morgan Chase & Co.
BRIEF

published on 02/28/2026 at 20:30, 2 months 6 days ago

DBV Technologies dévoile des résultats prometteurs de l'étude VITESSE de phase 3 lors du congrès AAAAI 2026

Résultats De La Phase 3 Étude VITESSE Technologies DBV Patch Aux Arachides VIASKIN Traitement De L'allergie Aux Arachides
BRIEF

published on 02/28/2026 at 20:30, 2 months 6 days ago

DBV Technologies Unveils Promising Phase 3 VITESSE Study Results at AAAAI 2026

DBV Technologies Phase 3 Results Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study
BRIEF

published on 02/28/2026 at 20:30, 2 months 6 days ago

DBV Technologies révèle de nouveaux résultats prometteurs pour VIASKIN Peanut

Immunothérapie Étude Clinique DBV Technologies Allergies Alimentaires Viaskin Peanut
BRIEF

published on 02/28/2026 at 20:30, 2 months 6 days ago

DBV Technologies reveals promising new results for VIASKIN Peanut

Clinical Study Immunotherapy DBV Technologies Food Allergies Viaskin Peanut
PRESS RELEASE

published on 02/28/2026 at 20:25, 2 months 6 days ago

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
DBV Technologies presents successful Phase 3 VITESSE study data at AAAAI Annual Meeting, highlighting VIASKIN Peanut Patch efficacy in treating peanut-allergic children

DBV Technologies Food Allergies Viaskin Peanut Patch Phase 3 VITESSE Study AAAAI Annual Meeting
PRESS RELEASE

published on 02/28/2026 at 20:25, 2 months 6 days ago

DBV Technologies présente des données positives supplémentaires de l’étude de phase 3 VITESSE à l’occasion du congres annuel AAAAI
DBV Technologies présente des données positives supplémentaires de l’étude de phase 3 VITESSE au Congrès annuel AAAAI. Effet thérapeutique significatif du patch VIASKIN Peanut chez enfants allergiques à l’arachide

DBV Technologies Patch Viaskin Peanut Enfants Allergiques Étude De Phase 3 VITESSE Effet Thérapeutique
BRIEF

published on 02/09/2026 at 22:35, 2 months 25 days ago

DBV Technologies to Join Guggenheim Biotech Summit

Biopharmaceutical DBV Technologies Food Allergies VIASKIN® Patch Guggenheim Securities Summit
BRIEF

published on 02/09/2026 at 22:35, 2 months 25 days ago

DBV Technologies at the Emerging Outlook: Biotech Summit conference

Immunotherapy DBV Technologies Viaskin Food Allergies Biotech Summit

Accesswire

Published on 05/07/2026 at 02:00, 54 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 3 hours 24 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 3 hours 49 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 3 hours 54 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 4 hours 44 minutes ago

Banyan Gold Announces Closing of $46.5 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 00:47, 2 hours 7 minutes ago

Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 2 hours 11 minutes ago

EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 6 hours 22 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 6 hours 32 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 7 hours 36 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/06/2026 at 18:00, 8 hours 54 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 8 hours 54 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 8 hours 54 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 8 hours 54 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 9 hours 9 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE